Picotamide is a
platelet aggregation inhibitor
An antiplatelet drug (antiaggregant), also known as a platelet agglutination inhibitor or platelet aggregation inhibitor, is a member of a class of pharmaceuticals that decrease platelet aggregation and inhibit thrombus formation. They are effectiv ...
. It works as a
thromboxane synthase inhibitor and a
thromboxane receptor inhibitor, the latter by modifying cellular responses to activation of the
thromboxane receptor
The thromboxane receptor (TP) also known as the prostanoid TP receptor is a protein that in humans is encoded by the ''TBXA2R'' gene, The thromboxane receptor is one among the five classes of prostaglandin receptor, prostanoid receptors and was ...
.
Picotamide is licensed in Italy for the treatment of clinical arterial thrombosis and peripheral artery disease.
References
Further reading
*
Antiplatelet drugs
3-Pyridyl compounds
Benzamides
Phenol ethers
{{blood-drug-stub